The Effects of the Aromatase Inhibitor A1-Testolactone on Gonadotropin Release and Steroid Metabolism in Polycystic Ovarian Disease*
- 1 April 1985
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 60 (4) , 773-780
- https://doi.org/10.1210/jcem-60-4-773
Abstract
This study was designed to examine the importance of aromatization in the gonadotropin secretory dynamics of polycystic ovarian disease (PCOt)) by using the aromatase inhibitor Δ1 testolactone (TL) as a probe and to determine the effects of TL on steroid metabolism in vivo and in vitro. The pulsatile patterns of gonadotropin secretion and peripheral steroid levels were studied in eight women with PCOD before and during TL administration. There was a significant fall in peripheral estrone (E1) levels, a rise in peripheral androstenedione levels, and an increase in the androstenedione⁄E1 ratio during TL administration in these women. Isotopic determinations of androgen and estrogen production and metabolism before and during TL administration in two women confirmed a 90-95‰ decrease in the overall rate of aromatization. One patient also had an increase in the production and clearance rates of estradiol and Ei during TL administration, suggesting resistance to TL of the ovarian aromatase enzyme system. There were significant increases in both mean LH pulse amplitude [1.2 ± 0.3 (SE) mlU⁄ ml LER-907 before vs. 1.7 ± 0.3 mlU⁄ml LER-907 during TL, P < 0.05, paired t test] and frequency per 6 h (median: 3 before vs. 4 during TL, P < 0.05, Wilcoxon signed rank test). Mean levels of LH and FSH did not, however, change significantly during TL administration. TL maximally inhibited neonatal rat hypothalamic aromatase in vitro at concentrations of 200 μM, a level theoretically obtainable during pharmacological therapy. These data suggest that: 1) in humans TL is a potent inhibitor of peripheral but not ovarian aromatase, and of hypothalamic aromatase in rats; 2) TL administration increases LH pulse amplitude and frequency in PCOD,. either directly via hypothalamic aromatase inhibition, or indirectly by alterations in gonadal steroid metabolism; and 3) because of the multiple potential actions of TL, its usefulness as a probe in studies of gonadotropin secretion in PCOD is limited.Keywords
This publication has 21 references indexed in Scilit:
- Aromatization of Androgens by Muscle and Adipose Tissue in Vivo*Journal of Clinical Endocrinology & Metabolism, 1978
- THE AROMATIZATION OF ANDROGENS BY PRIMARY MONOLAYER CULTURES OF FETAL RAT HYPOTHALAMUSEndocrinology, 1977
- Cytochrome P-450 and the aromatization of 16α-hydroxytestosterone and androstenedione by human placental microsomesMolecular and Cellular Endocrinology, 1976
- Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.Journal of Clinical Investigation, 1976
- Metabolic clearance rates and interconversions of estrone and 17β-estradiol in normal males and femalesJournal of Clinical Investigation, 1968
- Plasma Precursors of Estrogen. I. Extent of Conversion of Plasma Δ4-Androstenedione to Estrone in Normal Males and Nonpregnant Normal, Castrate and Adrenalectomized FemalesJournal of Clinical Endocrinology & Metabolism, 1967
- Testosterone and Androstenedione Blood Production Rates in Normal Women and Women with Idiopathic Hirsutism or Polycystic Ovaries*Journal of Clinical Investigation, 1967
- The isolation of urinary estrogens and determination of their specific activities following the administration of radioactive precursors to humansSteroids, 1963
- Δ1-testololactone, a nonandrogenic augmentor and inhibitor of androgensCancer, 1960
- Hormonal therapy in cancer of the breast.XVI. The effect of Δ1-testololactone on clinical course and hormonal excretionCancer, 1960